The Career Development Award (CDA) is a research grant that provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. The cancer research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed.
The Career Development Award (CDA) is a three-year cancer grant totaling $200,000, paid in three annual increments to the awardee’s institution.
The applicant must be a physician (MD, DO, or international equivalent) who is within the 1st to 3rd year of a full-time, primary faculty appointment in a clinical department at an academic medical institution at the time of grant submission. Grant applications from candidates with existing career development awards (such as K23, K08, or any other type of career development award) will not be considered.
For more informationon the Career Development Award (CDA), please read the most recent Request for Proposals.
2012 CDAs are supported by:
| The Breast Cancer Research Foundation | Genentech BioOncologyTM (4) |
| Eli Lilly and Company | Sarcoma Foundation of America |